Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Interest & Investment Income came in at $910000.0 in Q1 2026, up 54.76% year-on-year from $588000.0 in Q1 2025, and up 28.17% quarter-over-quarter from $710000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Interest & Investment Income across 4 years of filings, most recently posting $910000.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $910000.0, up 54.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 63.89% YoY), and the FY2025 annual result was $2.2 million, up 63.46% from the prior year.
- Interest & Investment Income came in at $910000.0 for Q1 2026 at Camp4 Therapeutics, up from $710000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $910000.0 in Q1 2026 to a low of $94000.0 in Q3 2024.
- The 4-year median for Interest & Investment Income is $569000.0 (2023), against an average of $515636.4.
- Across the five-year window, Interest & Investment Income plunged 86.36% in 2024 and surged 350.0% in 2025, its largest moves.
- Camp4 Therapeutics' Interest & Investment Income stood at $569000.0 in 2023, then advanced by 7.21% to $610000.0 in 2024, then climbed by 16.39% to $710000.0 in 2025, then rose by 28.17% to $910000.0 in 2026.
- The last three Interest & Investment Income figures came in at $910000.0 (Q1 2026), $710000.0 (Q4 2025), and $423000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | 910,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 710,000.00 |
| Sep 30, 2025 | 423,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 610,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 231,000.00 |
| Mar 31, 2024 | 395,000.00 |
| Dec 31, 2023 | 569,000.00 |
| Sep 30, 2023 | 689,000.00 |